Adlai Nortye Ltd. American Depositary Shares Total Liabilities
Adlai Nortye Ltd. American Depositary Shares total liabilities. Based on the latest financial reports, Adlai Nortye Ltd. American Depositary Shares (ANL) has total liabilities worth $42.76 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Adlai Nortye Ltd. American Depositary Sh asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Adlai Nortye Ltd. American Depositary Shares (2019–2025)
Total liabilities of Adlai Nortye Ltd. American Depositary Shares from 2019 to 2025. This chart illustrates how Adlai Nortye Ltd. American Depositary Shares's total liabilities have evolved over time, based on quarterly financial data. Explore ANL long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Adlai Nortye Ltd. American Depositary Shares Competitors by Total Liabilities
The table below lists competitors of Adlai Nortye Ltd. American Depositary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cheng Mei Materials Technology Corp
TW:4960
|
Taiwan | NT$5.78 Billion |
|
Firan Technology Group Corporation
TO:FTG
|
Canada | CA$70.91 Million |
|
NatWest Group PLC
LSE:NWG
|
UK | GBX705.97 Billion |
|
Hg Technologies Co Ltd
SHE:300847
|
China | CN¥140.67 Million |
|
Shandong Xinneng Taishan Power Generation Co Ltd
SHE:000720
|
China | CN¥2.75 Billion |
|
Tekla Life Sciences Investors
NYSE:HQL
|
USA | $2.40 Million |
|
Turkiye Sinai Kalkinma Bankasi AS
IS:TSKB
|
Turkey | TL251.26 Billion |
|
Adira Dinamika Multi Finance
JK:ADMF
|
Indonesia | Rp19.82 Trillion |
Liability Composition Analysis (2019–2025)
This chart breaks down Adlai Nortye Ltd. American Depositary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Adlai Nortye Ltd. American Depositary Sh balance sheet assets.
Liquidity & Leverage Metrics
Adlai Nortye Ltd. American Depositary Shares Total Liabilities Ratios Explained
Adlai Nortye Ltd. American Depositary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Adlai Nortye Ltd. American Depositary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Adlai Nortye Ltd. American Depositary Shares (2019–2025)
The table below shows the annual total liabilities of Adlai Nortye Ltd. American Depositary Shares from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $42.76 Million | -6.62% |
| 2024-12-31 | $45.78 Million | -16.97% |
| 2023-12-31 | $55.14 Million | -82.43% |
| 2022-12-31 | $313.89 Million | -1.02% |
| 2021-12-31 | $317.11 Million | +88.42% |
| 2020-12-31 | $168.30 Million | +109.90% |
| 2019-12-31 | $80.18 Million | -- |
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rect… Read more